Open-label comparative clinical study of chlorproguanil dapsone fixed dose combination (lapdap ) alone or with three different doses of artesunate for uncomplicated plasmodium falciparum malaria

HIGHLIGHTS

• who: Chlorproguanil et al. from the Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom, Malawi-Liverpool-Wellcome Trust Major Overseas Programme have published the article: Open-Label Comparative Clinical Study of Chlorproguanil Dapsone Fixed Dose Combination (Lapdap ) Alone or with Three Different Doses of Artesunate for Uncomplicated Plasmodium falciparum Malaria, in the Journal: (JOURNAL) of August/28,/2007
• what: The aim of this study was to determine the appropriate of artesunate for use in a therapy with chlorproguanil2dapsone (CPG2DDS) for the treatment of uncomplicated falciparum malaria.Methods: Open-label clinical trial comparing . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.